You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Venetoclax

Showing 1 - 25 of 352
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Nanjing (Venetoclax-Decitabine/Azacitidine-Aclarubicin Association,

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax-Decitabine/Azacitidine-Aclarubicin Association
  • Venetoclax-Decitabine/Azacitidine Association
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Mar 2, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jun 1, 2022

Chronic Myeloid Leukemia Trial in Jena (Venetoclax)

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Venetoclax
  • Jena, Germany
    Universitätsklinikum Jena
Jan 17, 2023

Acute Myeloid Leukemia, Measurable Disease Trial in Tianjin (Venetoclax, Azacitidine, Venetoclax, daunorubicin, cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Measurable Disease
  • Venetoclax, Azacitidine
  • Venetoclax, daunorubicin, cytarabine
  • Tianjin, Tianjin, China
    HBDH
Apr 28, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine, Navitoclax, Venetoclax)

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Venetoclax
  • +2 more
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Sep 15, 2022

AML Trial in Aurora (Venetoclax, CC-486)

Recruiting
  • AML
  • Aurora, Colorado
  • +1 more
Apr 4, 2022

Secondary Acute Myeloid Leukemia Trial in Nanjing (Venetoclax;Azacitidine;Homoharringtonine)

Recruiting
  • Secondary Acute Myeloid Leukemia
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Aug 21, 2022

Chronic Lymphocytic Leukemia Trial (Venetoclax)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Venetoclax
  • (no location specified)
Apr 2, 2022

AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

Not yet recruiting
  • AL Amyloidosis
  • Venetoclax Oral Tablet, 200 mg
  • +9 more
  • New York, New York
    New York Presbyterian Hospital/Columbia University Irving Medica
Jul 11, 2022

MDS, AML Trial in Bronx (Venetoclax, Decitabine)

Recruiting
  • MDS
  • AML
  • Bronx, New York
    Montefiore Medical Center
Jul 22, 2022

Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine Combined With Venetoclax and ATRA group
  • Suzhou, China
    the First Affiliated Hospital of Soochow University
Dec 8, 2022

Waldenstrom Macroglobulinemia Trial (Venetoclax; Rituximab, DRC)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • Venetoclax; Rituximab
  • DRC
  • (no location specified)
Jul 27, 2022

Acute Myeloid Leukemia Trial (with or without venetoclax)

Not yet recruiting
  • Acute Myeloid Leukemia
  • with or without venetoclax
  • (no location specified)
Apr 29, 2022

Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)

Enrolling by invitation
  • Myelodysplastic/Myeloproliferative Neoplasms
  • Adult
  • venetoclax combined with azacitidine
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Mar 7, 2022

Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)

Recruiting
  • Acute Myeloid Leukemia
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 13, 2022

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Tianjin (Olverembatinib, Venetoclax, prednisone)

Recruiting
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Oct 21, 2022

Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MYD88 Gene Mutation
  • Boston, Massachusetts
  • +1 more
Apr 1, 2022

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023

Mantle Cell Lymphoma Trial in Baltimore (Venetoclax Oral Tablet [Venclexta])

Recruiting
  • Mantle Cell Lymphoma
  • Venetoclax Oral Tablet [Venclexta]
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 29, 2022

Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Minimal Residual Disease Trial (Venetoclax, Decitabine,

Not yet recruiting
  • Relapsed Acute Myeloid Leukemia
  • +2 more
  • Venetoclax, Decitabine, Azacytidine, Cytarabine
  • (no location specified)
May 4, 2022

Venetoclax in Patients With Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 27, 2021

High Risk CLL, Chronic Lymphocytic Leukemia Trial (VenObi+Ven or VenObi+VenZan)

Not yet recruiting
  • High Risk CLL
  • Chronic Lymphocytic Leukemia
  • VenObi+Ven or VenObi+VenZan
  • (no location specified)
Jul 26, 2022

Acute Myeloid Leukemia, Relapsed Adult AML Trial (Lintuzumab-Ac225, Venetoclax, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Relapsed Adult AML
  • Lintuzumab-Ac225
  • +2 more
  • (no location specified)
Feb 22, 2022

CLL/SLL Trial in Belgium, Denmark, Netherlands (Venetoclax/Acalabrutinib)

Recruiting
  • CLL/SLL
  • Brussels, Belgium
  • +17 more
Mar 22, 2022